patents bpc 157 Multifunctionality and Possible Medical Application of the Peptide—Literature and Patent Review Did you know that there
Did you know that there is a patent on BPC 157? It's true! A company called Diagen, from Croatia, and Professor Predrag Sikiric are the primary holders of the patent. The BPC 157 Discovery and development by DIAGEN Diagen d.o.o. BPC 157 Stable Patent rights for sale Diagen d.o.o. UNDER SCRUTINY: Seven peptides go before advisory committee this week for uses ranging from weight loss and wound healing to opioid withdrawal. The compounds including BPC 157, MOTS c and Semax could
Pay in 4 interest-free payments of $6.96 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11


